Authors
No matching authors found
Try adjusting your search criteria
Advertisement
Advertisement
Trending on AJMC
1
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
2
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
3
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
4
The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD
5
